Related Experiment Videos
Estrogen inhibits fetal thymocyte development in vitro
A Rijhsinghani1, S K Bhatia, L Kantamneni
1Department of Obstetrics, University of Iowa, College of Medicine, Iowa City 52242, USA.
Summary
Estrogen inhibits fetal thymus development in vitro, contrary to in vivo observations. The intact fetus likely employs regulatory mechanisms to counteract estrogen
Area of Science:
- Immunology
- Developmental Biology
- Endocrinology
Background:
- Maternal thymus undergoes transient involution during pregnancy, mediated by estrogen.
- Estrogen crosses the placenta, yet fetal thymus enlarges with gestational age.
- The resistance of fetal thymocytes to estrogen's effects is not understood.
Purpose of the Study:
- To investigate the direct effect of estrogen on isolated fetal thymic glands in vitro.
- To determine if fetal thymocytes are inherently resistant to estrogen.
Main Methods:
- Fetal thymic lobes were isolated from 15-day gestation Balb/c mouse fetuses.
- Glands were cultured in vitro with varying concentrations of estrogen (0.5 and 1.0 mg/100 ml).
- Total thymocyte counts and phenotypic analysis using flow cytometry were performed after 12 days.
Main Results:
- Estrogen treatment significantly suppressed fetal thymocyte numbers.
- All T cell subsets (CD4+, CD8+, CD4+CD8+ double positive) were reduced.
- Early thymocyte developmental stages (triple negative compartment) showed depletion in later maturation stages.
Conclusions:
- Isolated fetal thymus is susceptible to estrogen's inhibitory effects.
- The intact fetus possesses a regulatory mechanism to neutralize estrogen's anti-lymphopoietic action.
- This mechanism explains the fetal thymus enlargement despite maternal estrogen exposure.